Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FANALE, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.060
EU - Europa 5.620
AS - Asia 4.578
SA - Sud America 805
Continente sconosciuto - Info sul continente non disponibili 574
AF - Africa 118
OC - Oceania 12
Totale 23.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.781
SG - Singapore 1.770
RU - Federazione Russa 1.514
CN - Cina 1.140
IT - Italia 1.091
FI - Finlandia 783
DE - Germania 659
BR - Brasile 628
HK - Hong Kong 457
VN - Vietnam 407
GB - Regno Unito 301
PL - Polonia 253
UA - Ucraina 222
FR - Francia 218
JP - Giappone 156
CA - Canada 151
IE - Irlanda 150
SE - Svezia 130
IN - India 120
KR - Corea 94
BD - Bangladesh 77
TR - Turchia 62
RO - Romania 55
IQ - Iraq 53
NL - Olanda 52
BE - Belgio 48
AR - Argentina 44
MX - Messico 42
AT - Austria 37
ES - Italia 37
CO - Colombia 35
EC - Ecuador 31
ZA - Sudafrica 26
VE - Venezuela 24
CI - Costa d'Avorio 23
IR - Iran 22
ID - Indonesia 20
UZ - Uzbekistan 20
PK - Pakistan 19
JM - Giamaica 17
MY - Malesia 17
MA - Marocco 15
NP - Nepal 15
AE - Emirati Arabi Uniti 14
CR - Costa Rica 14
PH - Filippine 14
CH - Svizzera 13
KE - Kenya 13
CL - Cile 12
KZ - Kazakistan 12
AU - Australia 11
CZ - Repubblica Ceca 10
HN - Honduras 10
AZ - Azerbaigian 9
EG - Egitto 9
IL - Israele 9
PE - Perù 9
SA - Arabia Saudita 9
NI - Nicaragua 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
DZ - Algeria 7
EU - Europa 7
KG - Kirghizistan 7
LT - Lituania 7
PY - Paraguay 7
TH - Thailandia 7
BG - Bulgaria 6
TW - Taiwan 6
BO - Bolivia 5
EE - Estonia 5
PA - Panama 5
PR - Porto Rico 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
CY - Cipro 4
GE - Georgia 4
GR - Grecia 4
JO - Giordania 4
LV - Lettonia 4
QA - Qatar 4
SV - El Salvador 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GA - Gabon 3
GT - Guatemala 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BS - Bahamas 2
DK - Danimarca 2
GD - Grenada 2
HU - Ungheria 2
Totale 23.173
Salva come PNG Salva come JPEG
Città #
Ashburn 1.596
Fairfield 1.130
Singapore 1.110
San Jose 872
Chandler 627
Woodbridge 604
Houston 483
Wilmington 472
Ann Arbor 461
Seattle 441
Hong Kong 429
Cambridge 369
Palermo 301
Moscow 272
Council Bluffs 243
Zgierz 205
Los Angeles 202
Santa Clara 191
New York 188
Beijing 171
Dallas 163
Helsinki 159
The Dalles 153
Tokyo 151
Dublin 147
Medford 145
Ho Chi Minh City 137
Chicago 134
Nanjing 118
Boardman 113
Jacksonville 108
Des Moines 106
Frankfurt am Main 104
Rome 100
Lauterbourg 98
Altamura 96
Hanoi 95
Princeton 94
Hefei 78
Lawrence 78
San Diego 73
Dearborn 70
São Paulo 63
Phoenix 57
Buffalo 51
Ludwigshafen am Rhein 50
Orem 48
Brussels 47
Milan 47
London 46
Jinan 44
Denver 43
Warsaw 43
Tulsa 39
Atlanta 38
Seoul 37
Nuremberg 35
Shenyang 35
Hebei 34
Brooklyn 33
Montreal 33
Bremen 31
Toronto 31
Kumar 30
Munich 29
Tianjin 29
Nanchang 27
Kitzingen 26
Stockholm 25
Rio de Janeiro 24
Venice 24
Abidjan 23
Brasília 22
Poplar 22
Amsterdam 21
Changsha 21
Johannesburg 21
Guangzhou 20
Chennai 19
Columbus 19
Izmir 19
Baghdad 18
Ningbo 18
Ankara 17
Falls Church 17
Haiphong 17
San Francisco 17
Tashkent 17
Boston 16
Jiaxing 16
San Paolo di Civitate 16
Turku 16
Mumbai 15
Seongnam 15
City of London 14
Hangzhou 14
Manchester 14
Pune 14
Saint Petersburg 14
Springfield 14
Totale 14.492
Salva come PNG Salva come JPEG
Nome #
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 371
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 357
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 344
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 341
Dietary restriction: could it be considered as speed bump on tumor progression road? 339
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 329
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 324
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 321
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 318
Breast cancer genome-wide association studies: there is strength in numbers 314
Anti-endothelin drugs in solid tumors 313
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 312
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 311
A headlight on liquid biopsies: a challenging tool for breast cancer management 310
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 309
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 308
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 304
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 299
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 296
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 290
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 287
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 284
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 283
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 282
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 281
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 280
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 279
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 277
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 277
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 277
The role of Aurora-A inhibitors in cancer therapy. 263
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 260
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 260
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 255
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 254
VUS variants in BRCA genes of hereditary breast/ovarian cancer 253
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 251
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 250
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 249
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 248
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 243
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 243
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 243
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 240
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 239
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 234
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 231
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway 230
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER 229
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer 228
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma 228
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 225
Non-coding RNAs functioning in colorectal cancer stem cells 223
Gene signatures in CRC and liver metastasis 221
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression 220
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 219
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 218
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 215
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 213
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 212
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 211
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 207
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 198
Effects of Dietary Restriction on Cancer Development and Progression 195
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 194
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 192
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 191
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 190
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 189
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 189
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 187
MUTYH-associated tumor syndrome: The other face of MAP 186
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 186
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 184
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 177
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 176
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 175
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 172
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 172
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 169
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 167
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 167
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies 166
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 165
Liquid Biopsy in Gastrointestinal Stromal Tumor 164
Circular RNA in Exosomes 163
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 163
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 162
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 158
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 153
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 153
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 149
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 145
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 144
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon 141
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 134
Scientific Communication and oncology – "The bridge between knowledge and patients" 134
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 129
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 128
role of CML exosomes in the crosstalk between chronic myelogenous leukaemia and bone marrow-derived cells 128
Totale 23.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022931 0 0 0 57 75 60 67 69 126 144 130 203
2022/20231.733 196 343 34 229 192 242 83 128 185 11 58 32
2023/2024972 42 101 53 60 58 212 104 135 6 46 11 144
2024/20252.716 23 225 216 170 140 110 308 245 123 357 338 461
2025/20268.394 724 290 468 711 897 1.319 1.133 816 594 865 282 295
2026/20271.790 356 257 1.008 169 0 0 0 0 0 0 0 0
Totale 23.767